NCT00878020View on ClinicalTrials.gov

Safety Study to Evaluate BMS-830216 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Obesity
Interventions
DRUG

BMS-830216

Capsules, Oral, Single Dose, 1 day

DRUG

Placebo

Capsules, Oral, 0mg, Single Dose, 1 day

DRUG

BMS-830216

Capsules, Oral, Single Dose on Day 1, Period 1 and Day 1, Period 2, 2 days

DRUG

Placebo

Capsules, Oral, 0mg, Single Dose, on Day 1, Period 1 and Day 1, Period 2, 2 days

Trial Locations (1)

78744

Ppd Development, Lp, Austin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00878020 - Safety Study to Evaluate BMS-830216 in Healthy Subjects | Biotech Hunter | Biotech Hunter